Cargando…

Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study

Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo techniq...

Descripción completa

Detalles Bibliográficos
Autores principales: Viganò, Luca, Lopci, Egesta, Di Tommaso, Luca, Destro, Annarita, Aghemo, Alessio, Rimassa, Lorenza, Solbiati, Luigi, Chiti, Arturo, Torzilli, Guido, Fiz, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501620/
https://www.ncbi.nlm.nih.gov/pubmed/36143097
http://dx.doi.org/10.3390/jcm11185451
_version_ 1784795519791398912
author Viganò, Luca
Lopci, Egesta
Di Tommaso, Luca
Destro, Annarita
Aghemo, Alessio
Rimassa, Lorenza
Solbiati, Luigi
Chiti, Arturo
Torzilli, Guido
Fiz, Francesco
author_facet Viganò, Luca
Lopci, Egesta
Di Tommaso, Luca
Destro, Annarita
Aghemo, Alessio
Rimassa, Lorenza
Solbiati, Luigi
Chiti, Arturo
Torzilli, Guido
Fiz, Francesco
author_sort Viganò, Luca
collection PubMed
description Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo technique to functionally assess the IH of ICC. Preoperative 18F-FDG PET-CT and intraoperative ultrasonography were merged to perform the intraoperative navigation of functional tumour heterogeneity. The tumour areas with the highest and the lowest metabolism (SUV) at PET-CT were selected, identified during surgery, and sampled. Three consecutive patients underwent the procedure. The areas with the highest uptake at PET-CT had higher proliferation index (KI67) values and higher immune infiltration compared to areas with the lowest uptake. One of the patients showed a heterogeneous presence of FGFR2 translocation within the samples. Tumour heterogeneity at PET-CT may drive biopsy to sample the most informative ICC areas. Even more relevant, these preliminary data show the possibility of achieving a non-invasive evaluation of IH in ICC, paving the way for an imaging-based precision-medicine approach.
format Online
Article
Text
id pubmed-9501620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95016202022-09-24 Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study Viganò, Luca Lopci, Egesta Di Tommaso, Luca Destro, Annarita Aghemo, Alessio Rimassa, Lorenza Solbiati, Luigi Chiti, Arturo Torzilli, Guido Fiz, Francesco J Clin Med Article Intra-tumoural heterogeneity (IH) is a major determinant of resistance to therapy and outcomes but remains poorly translated into clinical practice. Intrahepatic cholangiocarcinoma (ICC) often presents as large heterogeneous masses at imaging. The present study proposed an innovative in vivo technique to functionally assess the IH of ICC. Preoperative 18F-FDG PET-CT and intraoperative ultrasonography were merged to perform the intraoperative navigation of functional tumour heterogeneity. The tumour areas with the highest and the lowest metabolism (SUV) at PET-CT were selected, identified during surgery, and sampled. Three consecutive patients underwent the procedure. The areas with the highest uptake at PET-CT had higher proliferation index (KI67) values and higher immune infiltration compared to areas with the lowest uptake. One of the patients showed a heterogeneous presence of FGFR2 translocation within the samples. Tumour heterogeneity at PET-CT may drive biopsy to sample the most informative ICC areas. Even more relevant, these preliminary data show the possibility of achieving a non-invasive evaluation of IH in ICC, paving the way for an imaging-based precision-medicine approach. MDPI 2022-09-16 /pmc/articles/PMC9501620/ /pubmed/36143097 http://dx.doi.org/10.3390/jcm11185451 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Viganò, Luca
Lopci, Egesta
Di Tommaso, Luca
Destro, Annarita
Aghemo, Alessio
Rimassa, Lorenza
Solbiati, Luigi
Chiti, Arturo
Torzilli, Guido
Fiz, Francesco
Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title_full Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title_fullStr Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title_full_unstemmed Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title_short Functional Investigation of the Tumoural Heterogeneity of Intrahepatic Cholangiocarcinoma by In Vivo PET-CT Navigation: A Proof-of-Concept Study
title_sort functional investigation of the tumoural heterogeneity of intrahepatic cholangiocarcinoma by in vivo pet-ct navigation: a proof-of-concept study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501620/
https://www.ncbi.nlm.nih.gov/pubmed/36143097
http://dx.doi.org/10.3390/jcm11185451
work_keys_str_mv AT viganoluca functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT lopciegesta functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT ditommasoluca functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT destroannarita functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT aghemoalessio functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT rimassalorenza functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT solbiatiluigi functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT chitiarturo functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT torzilliguido functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy
AT fizfrancesco functionalinvestigationofthetumouralheterogeneityofintrahepaticcholangiocarcinomabyinvivopetctnavigationaproofofconceptstudy